drugset / Trial / NCT00370162

Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene

NCT00370162 ↗

Phase 3 Completed 30 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the safety of the gynaecological formulation in normal and usual usage condition.

Timeline

Start
2006-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject lactoserum Unknown — —

Indications

No indication recorded.